Bruce Eaton - 09 Aug 2021 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF BUSINESS OFFICER
Signature
/s/ Bruce Eaton
Issuer symbol
EDIT
Transactions as of
09 Aug 2021
Net transactions value
-$41,115
Form type
4
Filing time
04 Apr 2022, 16:30:15 UTC
Previous filing
30 Jul 2021
Next filing
10 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale $16,408 -287 -0.42% $57.17* 68,099 09 Aug 2021 Direct F1
transaction EDIT Common Stock Sale $24,707 -1,258 -1.8% $19.64 66,841 01 Apr 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2021. The sale does not represent a discretionary trade by the Reporting Person.
F2 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 31, 2022. The sale does not represent a discretionary trade by the Reporting Person.